-
公开(公告)号:US20220100985A1
公开(公告)日:2022-03-31
申请号:US17427086
申请日:2020-05-08
Applicant: Academia Sinica
Inventor: Yi-Sheng WANG , Chih-Hao HSIAO
IPC: G06K9/00
Abstract: Disclosed herein are methods and apparatus for reducing errors in spectroscopic measurements. The present method minimizes errors by aligning peak positions and recalculating intensities in every single-scan spectrum with reference to spectral features observed in the spectrum integrating all uncorrected single-scan spectra. Additionally, the corrected single-scan spectra are integrated to improve the resolving power, signal intensity and peak shape.
-
公开(公告)号:US20220090023A1
公开(公告)日:2022-03-24
申请号:US17418619
申请日:2019-12-26
Applicant: ACADEMIA SINICA
Inventor: Joyce Jean LU , Wei-Ju CHEN
IPC: C12N5/074 , C12N5/00 , C12N15/86 , C12N15/873 , C12N15/85 , C07K14/435
Abstract: The present invention relates to a method for regulating potency of pluripotent stem cells (PSCs) by modulating expression of podocalyxin-like protein 1 (PODXL) and applications thereof.
-
公开(公告)号:US11264601B2
公开(公告)日:2022-03-01
申请号:US16189005
申请日:2018-11-13
Applicant: National Chi Nan University , Academia Sinica
Inventor: Horng-Yi Tang , Maw-Kuen Wu , Yan-Ting Chen , Prem Chandan Devanga
IPC: H01M4/04 , H01M10/0525 , H01M4/485
Abstract: A method for making a vanadium pentoxide-based active material for a cathode of an alkali metal ion battery includes steps of: a) preparing an aqueous solution of a triazine derivative of Formula (I) wherein each R independently represents hydrogen or an amino group; and b) adding vanadium pentoxide to the aqueous solution of the triazine derivative under stirring, so as to permit condensation among hydrolyzed vanadium pentoxide along with self-assembly of the triazine derivatives to obtain a reaction solution containing the active material.
-
44.
公开(公告)号:US20210361706A1
公开(公告)日:2021-11-25
申请号:US17269612
申请日:2019-08-28
Applicant: ACADEMIA SINICA
Inventor: Nan-Shih LIAO , Shih-Wen HUANG , Zhen-Qi WU , Yein-Gei LAI , Yae-Huei LIOU
IPC: A61K35/17 , A61K31/675 , A61P35/00
Abstract: Combined therapy of cancer (e.g., breast cancer) involving a cyclophosphamide compound and natural killer (NK) cells. Also provided herein are methods for inducing immune memory and/or reducing the risk of tumor recurrence using the combined therapy of a cyclophosphamide compound and NK cells.
-
45.
公开(公告)号:US20210315966A1
公开(公告)日:2021-10-14
申请号:US17265090
申请日:2019-07-30
Applicant: Academia Sinica
Inventor: Che-Ming Jack Hu , Yu-Han Liu , Te-Li Chen
Abstract: A therapeutic nanoparticle containing a cationic polypeptide and a polyanionic molecule, in which the cationic polypeptide, exerting antibacterial activity, forms electrostatic interaction with the polyanionic molecule, and the therapeutic nanoparticle has a diameter of less than 50 nm. Also disclosed are a pharmaceutical composition, a treatment method, and a preparation method, all related to the therapeutic nanoparticle.
-
公开(公告)号:US20210292438A1
公开(公告)日:2021-09-23
申请号:US17340102
申请日:2021-06-07
Applicant: ACADEMIA SINICA
Inventor: Steve ROFFLER , Tian-Lu Cheng , Yu-Cheng Su , Kuo-Hsiang Chuang
IPC: C07K16/44 , A61K47/60 , A61K47/69 , A61P35/00 , A61K31/55 , A61K31/704 , A61K51/06 , C07K16/28 , C07K16/30 , C07K16/32 , G01N33/574
Abstract: A monomeric bispecific polyethylene glycol (PEG) engager that includes an anti-PEG Fab fused to a disulfide stabilized scFv that specifically binds to a cell surface antigen. The PEG engager, in the absence of PEG, remains monomeric upon binding to the cell surface antigen on a cell and remains on the surface of the cell. Also disclosed is a method for treating cancer by administering a PEG engager followed by a PEGylated anti-cancer agent. Further disclosed is a method for diagnosing a cell-mediated disorder by administering a PEG engager followed by a PEGylated diagnostic agent.
-
公开(公告)号:US11119078B2
公开(公告)日:2021-09-14
申请号:US16412704
申请日:2019-05-15
Applicant: ACADEMIA SINICA
Inventor: Chung-Hsuan Chen , Chen-Yu Hsieh , Jung-Lee Lin
Abstract: Apparatus and methods for high performance liquid chromatography. The apparatus includes a preparation loop comprising two linear stepping pumps, a sample loop comprising a sample injector, a chromatography column, and a detector device. The detector device can include a flash lamp, a flow cell, and a light sensor comprising an entrance slit, a grating; and a charge-coupled device array.
-
公开(公告)号:US11103567B2
公开(公告)日:2021-08-31
申请号:US16442334
申请日:2019-06-14
Applicant: Academia Sinica
Inventor: Shih-Hsiung Wu , Chung-Yi Wu , I-Ming Lee , Feng-Ling Yang
Abstract: Disclosed herein is a glycoconjugate vaccine conferring protection against a Gram negative pathogen infection, a method of manufacturing the glycoconjugate vaccine, and use of the glycoconjugate vaccine for treating bacterial infection. The glycoconjugate vaccine of the present disclosure has the structure of formula (I), wherein, L is a maleimide-type linker, which is connected to the carrier protein via a maleimide bond formed therebetween; and n and m are independently an integral or a non-integral number between 2 and 20.
-
公开(公告)号:US11086051B2
公开(公告)日:2021-08-10
申请号:US15599943
申请日:2017-05-19
Applicant: Academia Sinica
Inventor: Din-Ping Tsai , Pin-Chieh Wu
Abstract: The present invention provides an optical component comprising a dielectric layer and a nanorod array; the nanorod array is formed on a surface of the dielectric layer and extends along a lateral direction and a vertical direction. The nanorod array comprises a plurality of nanorods extending along the dielectric layer. The nanorods have a gap between one another, and an angle is defined by two adjacent nanorods. A bump is formed at each of two ends of the nanorod.
-
50.
公开(公告)号:US20210236647A1
公开(公告)日:2021-08-05
申请号:US16062274
申请日:2017-01-11
Applicant: Academia Sinica
Inventor: Han-Chung WU , Chen-Yun YEH
Abstract: An isolated or a synthetic targeting peptide comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 8 is disclosed. The targeting peptide may be conjugated to a component selected from the group consisting of polymeric micelles, lipoprotein-based drug carriers, nanoparticle drug carriers, a chemotherapeutic agent, a micelle, a liposome, dendrimers, a polymer, a lipid, an oligonucleotide, a peptide, a polypeptide, a protein, a prostate cancer cell, a stem cell, and an imaging agent. Also disclosed are a kit for imaging and detecting the presence of prostate cancer cells in vivo or in vitro, and a composition for treating prostate cancer, inhibiting prostate cancer cell growth, inducing prostate cancer cell cytotoxicity, and/or increasing the survival rate in a prostate cancer patient.
-
-
-
-
-
-
-
-
-